Four consecutive massive earnings beats averaging over 265% above consensus demonstrate consistent under-promising and over-delivering, but this favorable earnings dynamic coexists with operating margin compression of 65.5%, quality metrics below the investment floor, and virtually no remaining near-term price upside—making the current entry point unattractive despite the strong beat streak.
Thesis pillars
- Quality Below Floor Value Trap↑Improving
- Piotroski Strength Amid Margin Pressure→Stable
- Massive Earnings Beat Streak→Stable
- +1 more pillar — see the Why tab for full reasoning
InnovAge Holding Corp. (INNV) Stock Analysis
Catalyst-Driven edge
Healthcare · Medical Care Facilities
Sell if holding. Engine safety override at $9.08: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10 and A.R:R 1.6:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum.
InnovAge runs all-inclusive, capitated PACE programs for frail, mostly dual-eligible seniors, serving about 7,740 participants through 20 centers in California, Colorado, Florida, New Mexico, Pennsylvania and Virginia. It contracts directly with Medicare and Medicaid for... Read more
Sell if holding. Engine safety override at $9.08: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10 and A.R:R 1.6:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.8/10, moderate confidence.
Passes 5/8 gates (favorable risk/reward ratio, news events none recent, earnings proximity 19d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and clean insider activity. Suitability: aggressive.
About InnovAge Holding Corp.
About InnovAge Holding Corp.
InnovAge served approximately 7,740 participants through 20 PACE centers across California, Colorado, Florida, New Mexico, Pennsylvania and Virginia as of June 30, 2025, which the 10-K describes as the largest PACE provider in the United States by participants served. PACE accounted for 99.8% of revenue in both fiscal 2025 and 2024, and the typical participant has ten chronic conditions. The company is headquartered in Denver, Colorado.
InnovAge contracts directly with Medicare and Medicaid and receives capitated per member, per month payments, supplemented by Veterans Administration and private-pay sources, while taking on 100% of the cost of care for each participant. Revenue therefore depends on enrollment, participant acuity, reflected in an average Medicare Risk Adjustment Factor score of 2.42, and the company's ability to hold medical costs below the fixed payment. The company estimates an average annual revenue opportunity of $115,000 per participant, or $9,600 per member per month. Care is delivered through interdisciplinary care teams spanning at least 11 disciplines, purpose-built care centers, in-home services and virtual care, with transportation and third-party appointments managed by the company. The 10-K says InnovAge is 16% larger than its closest PACE-focused competitor and more than 30 times larger than the typical PACE operator. Growth levers include enrollment at existing centers, de novo centers in Tampa and Orlando, and tuck-in acquisitions such as the December 2023 purchase of two ConcertoCare PACE programs in California.
Show full overview
Regulatory scrutiny is the sharpest exposure. Starting in 2021, federal and state audits led CMS and regulators in California and Colorado to suspend new enrollments at the Sacramento center and the Colorado centers, with the sanctions lifted in 2023. California's Department of Health Care Services later suspended state-required attestations for planned de novo centers in Downey and Bakersfield, and there is no guarantee they will be reinstated. Separately, reductions to the Medicaid portion of PACE capitation rates under the One Big Beautiful Bill Act may shrink the addressable market, and six-month Medicaid redeterminations could slow enrollment and raise revenue recovery risk.
See also: Healthcare · Medical Care Facilities
From InnovAge Holding Corp.'s most recent 10-K filing, extracted October 11, 2026.
Recent developments
updated 2026-10-15Recent Developments — InnovAge Holding Corp.
Latest news
- NEWS InnovAge (NASDAQ:INNV) Issues Earnings Results - MarketBeat — MarketBeat neutral
- NEWS InnovAge (INNV) to Release Quarterly Earnings on Tuesday - MarketBeat — MarketBeat neutral
- NEWS Earnings call transcript: InnovAge Q3 2026 sees revenue growth, stock rise - Investing.com — Investing.com positive
- NEWS Earnings call transcript: InnovAge Q3 2026 sees revenue growth, stock rise - Investing.com Canada — Investing.com Canada positive
- NEWS InnovAge Holding Corp. (INNV) Reports Q3 Loss, Beats Revenue Estimates - Yahoo! Finance Canada — Yahoo! Finance Canada positive
Generated 2026-10-15T11:37:20Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductPACE program100%10-K Item 1A: 'We receive nearly all of our revenue through the PACE program, which accounted for 99.8% of our revenue for each of the years ended June 30, 2025 and 2024.'
- MEDIUMCustomerlimited number of government payors10-K Item 1A: 'a majority of our revenue was derived from a limited number of government payors.'
Material Events(8-K, last 90d)
- 2026-05-12Item 5.02LOWBoard appointed Jennifer Browne, formerly COO of Strive Health, as President and Chief Operating Officer effective June 8, 2026, with an employment agreement. No predecessor departure cited.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Unprofitable operations — net margin -0.3%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $9.08: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10 and A.R:R 1.6:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $8.46. Score 5.8/10, moderate confidence.
Take-profit target: $10.20 (+12.3% upside). Prior stop was $8.46. Stop-loss: $8.46.
Concentration risk — Product: PACE program (99.8%); Quality below floor (3.9 < 4.0); Value-trap signals (2/5): Revenue declining (-7.6% YoY), Margin compression (op margin -0.3%).
InnovAge Holding Corp. trades at a P/E of N/A (forward 18.2). TrendMatrix value score: 7.0/10. Verdict: Sell.
9 analysts cover INNV with a consensus score of 2.4/5. Average price target: $12.
What does InnovAge Holding Corp. do?InnovAge runs all-inclusive, capitated PACE programs for frail, mostly dual-eligible seniors, serving about 7,740...
InnovAge runs all-inclusive, capitated PACE programs for frail, mostly dual-eligible seniors, serving about 7,740 participants through 20 centers in California, Colorado, Florida, New Mexico, Pennsylvania and Virginia. It contracts directly with Medicare and Medicaid for per-member monthly payments and bears 100% of participant care costs. It describes itself as the largest PACE provider in the US by participants.